PHK
LUMO

Point72 Hong Kong’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Point72 Hong Kong’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Hold
0
– – – 1239
2018
Q2 		– Sell
-306
Closed -$14K – 1242
2018
Q1 		$20K Buy
306
+290
+1,813% +$20.5K 0.01% 617
2017
Q4 		$1K Buy
+16
New +$1.32K ﹤0.01% 802
2017
Q2 		– Sell
-23
Closed -$5K – 1063
2017
Q1 		$5K Buy
+23
New +$3.29K 0.01% 575

Other funds holding LUMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Hong Kong's LUMO Position: Q3 2018 in Review

Point72 Hong Kong held its Lumos Pharma, Inc. Common Stock (LUMO) position steady in Q3 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1239.

Point72 Hong Kong first reported a position in LUMO in Q1 2017 and has held it in 3 quarters since. The position peaked at $20K in Q1 2018. 92 funds tracked by Wall St. Rank hold LUMO as of Q3 2018.

  • Point72 Hong Kong held 0 shares of Lumos Pharma, Inc. Common Stock worth $0 as of Q3 2018.
  • Point72 Hong Kong left its Lumos Pharma, Inc. Common Stock share count unchanged in Q3 2018.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Point72 Hong Kong's portfolio in Q3 2018, its #1239 holding.
  • Point72 Hong Kong first reported a position in Lumos Pharma, Inc. Common Stock in Q1 2017 and has held it in 3 quarters since.
  • Point72 Hong Kong's Lumos Pharma, Inc. Common Stock position peaked at $20K in Q1 2018.
  • 92 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2018.

Based on Point72 Hong Kong's 13F filing for Q3 2018, filed 14 Nov 2018.